Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Acute haemothorax secondary to ibrutinib: A case report
JSY Wong, S Sadullah - EJHaem, 2022 - ncbi.nlm.nih.gov
Mantle cell lymphoma (MCL) is a subtype of non-Hodgkin lymphoma that frequently follows
an aggressive clinical course, with 5-year overall survival (OS) ranging from 17% to 85%[1] …
an aggressive clinical course, with 5-year overall survival (OS) ranging from 17% to 85%[1] …
Ibrutinib-associated alveolar hemorrhage and spontaneous hemothorax
tein: 5 g/dl), albumin: 2.53 g/dl (serum albumin: 2.9 g/dl). Hematocrit of pleural fluid to serum
hematocrit ratio was 0.93. A catheter thoracostomy with a 12-French chest catheter was …
hematocrit ratio was 0.93. A catheter thoracostomy with a 12-French chest catheter was …
[HTML][HTML] Ibrutinib-Associated Life-Threatening Hemorrhage with Subcapsular Renal Hematoma and Hemothorax
P Gaudel, A Brubaker, C Huang… - Archives of Clinical …, 2022 - fortuneonline.org
Background: Ibrutinib is an irreversible inhibitor of Bruton tyrosine kinase (BTK) which is
FDA approved for treatment of chronic lymphocytic leukemia (CLL) and multiple other B-cell …
FDA approved for treatment of chronic lymphocytic leukemia (CLL) and multiple other B-cell …